MANCHESTER, England, Sept. 2, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, today announced that it has engaged Anthony Amato and his firm, Bridge Associates International Pharmaceutical Consulting (BAIPC), to support specific strategic initiatives in support of the Company's long-term growth initiatives.Mr. Amato brings extensive executive and consulting experience in the life sciences and technology sectors. He ...